UniProtKB/Swiss-Prot P35579: Variant p.Arg702His

Myosin-9
Gene: MYH9
Chromosomal location: 22q13.1
Variant information

Variant position:  702
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Disease [Disclaimer]
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants have been found in patients and disease-association is reported in literature. However, this classification is not a definitive assessment of variant pathogenicity.
  • Polymorphism: No disease-association has been reported.
  • Unclassified: Variants have been found in patients but disease-association remains unclear.

Residue change:  From Arginine (R) to Histidine (H) at position 702 (R702H, p.Arg702His).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from large size and basic (R) to medium size and polar (H)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In APSM and EPS.
Any additional useful information about the variant.



Sequence information

Variant position:  702
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  1960
The length of the canonical sequence.

Location on the sequence:   KLDPHLVLDQLRCNGVLEGI  R ICRQGFPNRVVFQEFRQRYE
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         KLDPHLVLDQLRCNGVLEGIRICRQGFPNRVVFQEFRQRYE

Mouse                         KLDPHLVLDQLRCNGVLEGIRICRQGFPNRVVFQEFRQRYE

Rat                           KLDPHLVLDQLRCNGVLEGIRICRQGFPNRVVFQEFRQRYE

Dog                           KLDPHLVLDQLRCNGVLEGIRICRQGFPNRVVFQEFRQRYE

Chicken                       KLDPHLVLDQLRCNGVLEGIRICRQGFPNRVVFQEFRQRYE

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 2 – 1960 Myosin-9
Domain 81 – 776 Myosin motor


Literature citations

Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.
Heath K.E.; Campos-Barros A.; Toren A.; Rozenfeld-Granot G.; Carlsson L.E.; Savige J.; Denison J.C.; Gregory M.C.; White J.G.; Barker D.F.; Greinacher A.; Epstein C.J.; Glucksman M.J.; Martignetti J.A.;
Am. J. Hum. Genet. 69:1033-1045(2001)
Cited for: VARIANTS MHA/SBS/FTNS/EPS/APSM ASN-373; CYS-702; HIS-702; PRO-1114; ASN-1424; HIS-1424 AND LYS-1841;

Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene.
Seri M.; Savino M.; Bordo D.; Cusano R.; Rocca B.; Meloni I.; Di Bari F.; Koivisto P.A.; Bolognesi M.; Ghiggeri G.M.; Landolfi R.; Balduini C.L.; Zelante L.; Ravazzolo R.; Renieri A.; Savoia A.;
Hum. Genet. 110:182-186(2002)
Cited for: VARIANT EPS HIS-702;

MYH9-related disease: may-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness.
Seri M.; Pecci A.; Di Bari F.; Cusano R.; Savino M.; Panza E.; Nigro A.; Noris P.; Gangarossa S.; Rocca B.; Gresele P.; Bizzaro N.; Malatesta P.; Koivisto P.A.; Longo I.; Musso R.; Pecoraro C.; Iolascon A.; Magrini U.; Rodriguez Soriano J.; Renieri A.; Ghiggeri G.M.; Ravazzolo R.; Balduini C.L.; Savoia A.;
Medicine (Baltimore) 82:203-215(2003)
Cited for: VARIANT EPS HIS-702; VARIANTS FTNS GLN-910; ILE-1155 AND HIS-1424; VARIANTS MHA/SBS 1066-GLU--ALA-1072 DEL AND ASN-1424; VARIANT EPS/FTNS/MHA/SBS CYS-702;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.